Cargando…
Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination
During the coronavirus disease 2019 (COVID-19) pandemic, COVID-19 vaccination-induced hyperglycemia and related complications have been reported. However, there have been few reports of type 1 diabetes triggered by COVID-19 vaccines in subjects without diabetes. Here, we report the case of a 56-year...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829515/ https://www.ncbi.nlm.nih.gov/pubmed/36625174 http://dx.doi.org/10.3346/jkms.2023.38.e12 |
_version_ | 1784867475247071232 |
---|---|
author | Moon, Hyeyeon Suh, Sunghwan Park, Mi Kyoung |
author_facet | Moon, Hyeyeon Suh, Sunghwan Park, Mi Kyoung |
author_sort | Moon, Hyeyeon |
collection | PubMed |
description | During the coronavirus disease 2019 (COVID-19) pandemic, COVID-19 vaccination-induced hyperglycemia and related complications have been reported. However, there have been few reports of type 1 diabetes triggered by COVID-19 vaccines in subjects without diabetes. Here, we report the case of a 56-year-old female patient who developed hyperglycemia after the second dose of COVID-19 mRNA-based vaccination without a prior history of diabetes. She visited our hospital with uncontrolled hyperglycemia despite administration of oral hyperglycemic agents. Her initial glycated hemoglobin level was high (11.0%), and fasting serum C-peptide level was normal. The fasting serum C-peptide level decreased to 0.269 ng/mL 5 days after admission, and the anti-glutamic acid decarboxylase antibody was positive. The patient was discharged in stable condition with insulin treatment. To our knowledge, this is the first case of the development of type 1 diabetes without diabetic ketoacidosis after mRNA-based COVID-19 vaccination, and is the oldest case of type 1 diabetes development under such circumstances. |
format | Online Article Text |
id | pubmed-9829515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Korean Academy of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-98295152023-01-19 Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination Moon, Hyeyeon Suh, Sunghwan Park, Mi Kyoung J Korean Med Sci Case Report During the coronavirus disease 2019 (COVID-19) pandemic, COVID-19 vaccination-induced hyperglycemia and related complications have been reported. However, there have been few reports of type 1 diabetes triggered by COVID-19 vaccines in subjects without diabetes. Here, we report the case of a 56-year-old female patient who developed hyperglycemia after the second dose of COVID-19 mRNA-based vaccination without a prior history of diabetes. She visited our hospital with uncontrolled hyperglycemia despite administration of oral hyperglycemic agents. Her initial glycated hemoglobin level was high (11.0%), and fasting serum C-peptide level was normal. The fasting serum C-peptide level decreased to 0.269 ng/mL 5 days after admission, and the anti-glutamic acid decarboxylase antibody was positive. The patient was discharged in stable condition with insulin treatment. To our knowledge, this is the first case of the development of type 1 diabetes without diabetic ketoacidosis after mRNA-based COVID-19 vaccination, and is the oldest case of type 1 diabetes development under such circumstances. The Korean Academy of Medical Sciences 2022-12-08 /pmc/articles/PMC9829515/ /pubmed/36625174 http://dx.doi.org/10.3346/jkms.2023.38.e12 Text en © 2023 The Korean Academy of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Moon, Hyeyeon Suh, Sunghwan Park, Mi Kyoung Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination |
title | Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination |
title_full | Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination |
title_fullStr | Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination |
title_full_unstemmed | Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination |
title_short | Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination |
title_sort | adult-onset type 1 diabetes development following covid-19 mrna vaccination |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829515/ https://www.ncbi.nlm.nih.gov/pubmed/36625174 http://dx.doi.org/10.3346/jkms.2023.38.e12 |
work_keys_str_mv | AT moonhyeyeon adultonsettype1diabetesdevelopmentfollowingcovid19mrnavaccination AT suhsunghwan adultonsettype1diabetesdevelopmentfollowingcovid19mrnavaccination AT parkmikyoung adultonsettype1diabetesdevelopmentfollowingcovid19mrnavaccination |